| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AMBALAL SARABHAI ENTERPRISES LTD. (BSE: 500009)
500009 Technical Analysis
2
| As on 8th May 2024 500009 SHARE Price closed @ 46.53 and we RECOMMEND Buy for LONG-TERM with Stoploss of 40.77 & Strong Sell for SHORT-TERM with Stoploss of 50.37 we also expect STOCK to react on Following IMPORTANT LEVELS. |
500009SHARE Price
| Open | 43.39 | Change | Price | % |
| High | 48.50 | 1 Day | 3.39 | 7.86 |
| Low | 43.00 | 1 Week | 0.13 | 0.28 |
| Close | 46.53 | 1 Month | -5.42 | -10.43 |
| Volume | 242309 | 1 Year | 23.98 | 106.34 |
| 52 Week High 70.00 | 52 Week Low 20.90 | ||||
BSE INDIA Most Active Stocks
| 532822 | 12.71 | 2.67% |
| 532648 | 22.98 | 0.48% |
| 532775 | 1.62 | -0.61% |
| 517001 | 0.09 | 12.50% |
| 533098 | 98.84 | 1.75% |
| 511389 | 7.25 | -2.42% |
| 534690 | 7.65 | 4.79% |
| 512149 | 1.13 | -1.74% |
| 530557 | 0.70 | 0.00% |
| 532532 | 17.62 | -0.11% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 500009 Daily Charts |
500009 Intraday Charts |
Whats New @ Bazaartrend |
500009 Free Analysis |
|
|
500009 Important Levels Intraday
| RESISTANCE | 57.13 |
| RESISTANCE | 53.73 |
| RESISTANCE | 51.63 |
| RESISTANCE | 49.53 |
| SUPPORT | 43.53 |
| SUPPORT | 41.43 |
| SUPPORT | 39.33 |
| SUPPORT | 35.93 |
500009 Target May 2024
| 4th UP Target | 67.79 |
| 3rd UP Target | 60.93 |
| 2nd UP Target | 56.69 |
| 1st UP Target | 52.45 |
| 1st DOWN Target | 40.35 |
| 2nd DOWN Target | 36.11 |
| 3rd DOWN Target | 31.87 |
| 4th DOWN Target | 25.01 |
500009 Weekly Target
| 4th UP Target | 52.99 |
| 3rd UP Target | 50.58 |
| 2nd UP Target | 49.09 |
| 1st UP Target | 47.60 |
| 1st DOWN Target | 43.34 |
| 2nd DOWN Target | 41.85 |
| 3rd DOWN Target | 40.36 |
| 4th DOWN Target | 37.95 |
500009 Target2024
| 4th UP Target | 91.9 |
| 3rd UP Target | 74.62 |
| 2nd UP Target | 63.94 |
| 1st UP Target | 53.26 |
| 1st DOWN Target | 22.78 |
| 2nd DOWN Target | 12.1 |
| 3rd DOWN Target | 1.42 |
| 4th DOWN Target | -15.86 |
AMBALAL SARABHAI ENTERPRISES LTD. ( BSE INDIA Symbol : 500009 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
500009 Business Profile
Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. It operates through Pharmaceuticals and Electronics segments. The company offers products for oncology, infertility, and uro-gynaec areas under the Sarabhai house name; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio products, and electronic products. Ambalal Sarabhai Enterprises Limited was founded in 1880 and is based in Ahmedabad, India. Address: Shanti Sadan, Ahmedabad, India, 380001
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service